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Abstract. 
 
Retinal ganglion cell axons grow towards the 
optic ﬁssure in close contact with the basal membrane, 
an excellent growth substratum. One of the ligands of 
receptor tyrosine phosphatase CRYP
 
a
 
 is located on the 
retinal and tectal basal membranes. To analyze the role 
of this RPTP and its ligand in intraretinal growth and 
guidance of ganglion cell axons, we disrupted ligand-
receptor interactions on the retinal basal membrane in 
culture. Antibodies against CRYP
 
a
 
 strongly reduced 
retinal axon growth on the basal membrane, and in-
duced a dramatic change in morphology of retinal 
growth cones, reducing the size of growth cone lamelli-
podia. A similar effect was observed by blocking the 
ligand with a CRYP
 
a
 
 ectodomain fusion protein. These 
effects did not occur, or were much reduced, when ax-
ons were grown either on laminin-1, on matrigel or on 
basal membranes with glial endfeet removed. This indi-
cates that a ligand for CRYP
 
a
 
 is located on glial end-
feet. These results show for the ﬁrst time in vertebrates 
that the interaction of a receptor tyrosine phosphatase 
with its ligand is crucial not only for promotion of reti-
nal axon growth but also for maintenance of retinal 
growth cone lamellipodia on basal membranes.
Key words: receptor protein tyrosine phosphatase • 
axon growth • actin cytoskeleton • growth cone • in-
tegrin
 
O
 
NE
 
 of the first steps in retinal axon growth occurs
early in development in the retina. During the
process of intraretinal axon guidance, ganglion
cell axons grow towards the optic fissure and exit the eye
at the optic nerve head to reach their visual centers in the
brain. In the chick embryo, the first retinal ganglion cell
axons are found in the central retina at Hamburger-
Hamilton (HH) stage 15 (E2-E3), shortly after invagina-
tion of the optic vesicle (Mey and Thanos, 1992). From the
earliest stages onwards these axons grow straight to the
optic fissure. As more and more ganglion cells differenti-
ate and send out axons, fascicles form which also head di-
rectly to the fissure. In recent years, several mechanisms
have been suggested to account for intraretinal axon guid-
ance.
Neurolin, the goldfish homologue of DM-GRASP, is in-
volved in guidance of dorsal retinal axons towards the op-
tic disc (Ott et al., 1998). Neurolin is a member of the im-
munoglobulin superfamily consisting of five extracellular
Ig domains, a transmembrane region, and a short cytoplas-
mic sequence. In vivo injections of monoclonal antibodies
against Ig domains 1 and 3 resulted in defasciculation of
retinal axons, whereas antibodies directed against Ig do-
main 2 led to intraretinal guidance errors of ganglion cell
axons (Leppert et al., 1999). The direct growth towards the
optic disc also requires other immunoglobulin superfamily
members like L1 and N-CAM (Brittis and Silver, 1995;
Brittis et al., 1995). Injection of Fab fragments against
E587, a member of the L1 subfamily, resulted in a delay of
fasciculation of young axons as well as defasciculation
(Bastmeyer et al., 1995; Giordano et al., 1997).
A role for the FGF receptor (FGFR), a receptor ty-
rosine kinase, in guidance of retinal ganglion cell axons to-
ward the fissure became evident after adding receptor-
specific antibodies to living whole-mount rat retinae.
Blocking of the FGFR resulted in defasciculation of reti-
nal axons in the center of the retina and in guidance errors
in the retinal periphery (Brittis et al., 1996). In 
 
Xenopus
 
retinae, in 
 
.
 
40% of retinal ganglion cells expressing a
truncated, kinase-defective FGFR, axons were unable to
leave the retina (McFarlane et al., 1996). These observa-
tions underscore the importance of the FGFR in intrareti-
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nal axon guidance and in the exit of retinal axons from
the eye. The results are at least partially explained by the
function of this receptor in mediating the effects of N-cad-
herin, NCAM, and L1 (reviewed in Viollet and Doherty,
1997), other cell adhesion molecules and components of
the ECM.
Chondroitin sulfate proteoglycan, a major component of
the ECM, was suggested to act as an inhibitory molecule,
preventing growth of retinal axons towards the periphery
(Brittis et al., 1992). Having reached the optic disc, axons
start to exit from the eye to enter the optic nerve. In the
mouse embryo, netrin-1 seems to be responsible for the exit
of retinal axons but not for their growth towards the optic
disc (Deiner et al., 1997). In the eye, retinal axons grow in
close contact to an extracellular matrix structure, the
basal lamina or basal membrane (BM) (Rager, 1980; Eas-
ter et al., 1984; Silver and Rutishauser, 1984; Halfter and
Boxberg, 1992; Halfter 1996). The retinal basal lamina
(membrana limitans interna) is an excellent growth sub-
stratum for retinal axons and is superior to laminin
(Halfter, 1996) and, moreover, extremely important dur-
ing early stages of neural development (Halfter, 1998). Its
outgrowth promoting activities, however, are not com-
pletely characterized. Important molecular components
of this structure include laminin, nidogen, collagen IV,
agrin, heparan sulfate proteoglycan, chondroitin sulfate
proteoglycan, tenascin,
 
 
 
and at least 10 unidentified extra-
cellular matrix components (Halfter and Boxberg, 1992;
Halfter, 1996; Faissner, 1997). Among these unidentified
molecules are probably candidates contributing to the
excellent growth-stimulating characteristics of the reti-
nal BM.
We became interested in studying the retinal basal
membrane in more detail because of the recent find-
ing that several receptor protein tyrosine phosphatases
(RPTPs)
 
1
 
, including CRYP
 
a
 
 (Stoker, 1994), CRYP-2
(Bodden and Bixby, 1996), and PTP
 
m
 
 (Gebbink et al.,
1991), are expressed on retinal axons and growth cones
during formation of the retinotectal projection (Stoker et al.,
1995a; Ledig et al., 1999). CRYP
 
a
 
 is a member of the type
IIa subfamily of RPTPs. This subfamily is of particular in-
terest given their structural resemblance to the neural
CAMs (see Fig. 1) and their expression pattern in the de-
veloping CNS (Schaapveld et al., 1998). This structure sug-
gested that they would have extracellular ligands either on
cells or in the extracellular matrix. Although the identity
of these ligands remains to be determined, it appears that
at least one of these is present on the retinal BM (Haj et al.,
1999).
To date the function of these RPTPs during nervous sys-
tem development in vertebrates remains largely to be de-
termined (Stoker and Dutta, 1998; van Vactor, 1998).
Most of what we know about the function and signaling
mechanisms of RPTPs comes from studies in 
 
Drosophila
 
(Desai et al., 1997a). The 
 
Drosophila
 
 RPTPs, DLAR,
DPTP69D, and DPTP99A are required for motor axon
 
guidance (Desai et al., 1996, 1997b; Krueger et al., 1996).
Signals downstream of DLAR also control the actin cy-
toskeleton of axons (Wills et al., 1999a,b). In vertebrates,
very recent data (Uetani et al., 1997; Elchebly et al., 1999;
Wallace et al., 1999) also indicate that at least PTP
 
s
 
(CRYP
 
a
 
 is the chick orthologue of PTP
 
s
 
) and PTP
 
d
 
 (Mi-
zuno et al., 1993) are important for proper development of
the central nervous system. PTP
 
m
 
, belonging to the same
type II family of PTPs as CRYP
 
a
 
, was also recently de-
scribed as being important for regulating cadherin-medi-
ated retinal axon outgrowth (Burden-Gulley and Brady-
Kalnay, 1999).
We have addressed the question of CRYP
 
a
 
 function in
early retinal axons by attempting to perturb functionally
the interactions of CRYP
 
a
 
1 with its ligand in the in vivo
substrate, the retinal BM. The presence of a BM ligand
was demonstrated in vitro using a fusion protein consisting
of the ectodomain of CRYP
 
a
 
1 and the enzyme alkaline
phosphatase (
 
a
 
1-AP) (see Fig. 1 for structures). This pro-
tein prominently binds to the BM (Haj et al., 1999). To an-
alyze the potential function of the CRYP
 
a
 
 ligand, we grew
retinal axons on retinal BMs (Halfter et al., 1987) and
treated them either with CRYP
 
a
 
 specific antibodies or
with soluble 
 
a
 
1-AP. Both the axonal growth rate and the
growth cone morphology of retinal neurons were strongly
influenced by these reagents. Significantly, on BMs with
endfeet removed (BM-Ef) and on an artificial acellular
BM (matrigel),
 
 
 
these effects were sharply reduced. We
conclude that CRYP
 
a
 
 and its ligand on glial endfeet play
important roles in promoting retinal axon growth and
maintenance of growth cone morphology.
 
Materials and Methods
 
Antibodies and Reagents
 
The generation of the polyclonal antibody anti-CRYP
 
a
 
 and its purifica-
tion have been previously described (Stoker et al., 1995a). The polyclonal
anti-NCAM antibody and its function-blocking activity have been charac-
terized (Bixby and Reichardt, 1987; Bixby et al., 1987). The monoclonal
antibody against 
 
b
 
1
 
-integrin was JG22 (Greve and Gottlieb, 1982; Toma-
selli et al., 1986). The CRYP
 
a
 
1-AP and Ig3-AP fusion proteins were gen-
erated by subcloning CRYP
 
a
 
1 fragments spanning amino acids 1–721 and
1–316 into the APtag2 vector (Cheng et al., 1995; Haj et al., 1999). AP was
generated by transfecting the APtag4 vector (Cheng et al., 1995).
 
 
 
All
three vectors were transfected into cos7 or 293T cells using Superfect
 
TM
 
(Qiagen) and the proteins were collected after 6 d in the conditioned me-
dium. Medium was passed through an anti-AP agarose column (Sigma),
and the fusion protein eluted using 0.1 M glycine-HCl, pH 2.5, with imme-
diate buffering to pH 8 with Tris-HCl. The protein was dialyzed against
TBS buffer and stored at 4
 
8
 
C. Laminin-1 and matrigel were obtained from
Becton Dickinson. N-cadherin was purified as described (Bixby and
Zhang, 1990).
 
AP Staining
 
E6 retinal cryosections were prepared as previously described (Ledig et al.,
1999) and incubated with 
 
a
 
1-AP. The AP staining method was also previ-
ously described (Cheng et al., 1995; Haj et al., 1999).
 
Culture of Retinal Explants: The Basal
Membrane Assay
 
The basal membrane assay was performed as described in Halfter et al.
(1987). The basal lamina was prepared from E7 retina. In the first step,
the retina is flatmounted on a nitrocellulose filter (Sartorius AG). The fil-
ter with the attached retina is then put upside down on a poly-
 
L
 
-lysine
(PLL)-coated glass coverslip (see Fig. 2 A). Two small metal bars are put
 
1. 
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on the filter before it is incubated for 10 min at 37
 
8
 
C. Afterwards the filter
is lifted up while the basal lamina sticks to the glass surface (see Fig. 2 B).
To remove the glial endfeet from the basal lamina, glass coverslips were
washed with 2% Triton X-100 for 5 min. The Triton was removed after
three 10-min wash steps with Hank’s solution.
 
 
 
For experiments with lami-
nin as a growth substrate glass coverslips were coated with laminin at 37
 
8
 
C
for 2 h and afterwards washed with Hank’s. Coating of glass coverslips
with matrigel was carried out according to the manufacturer’s protocol.
For experiments with N-cadherin as a growth substrate, PLL-precoated
glass coverslips were coated with N-cadherin at 37
 
8
 
C for 3 h, resulting in a
PLL/N-cadherin substrate mix.
 
 
 
Retinal explants as outgrowth source were
prepared from E6 retinae as previously described (Ledig et al., 1999). Cul-
tures were incubated for 24 h at 37
 
8
 
C in 1 ml F12 medium containing
methylcellulose and various amounts of preadded different antibody in a
humidified chamber (5% CO
 
2
 
).
 
Staining of Retinal Cultures
 
After incubation cultures were immediately fixed in 4% paraformalde-
hyde (dissolved in 0.1 M phosphate buffer) for 10 min at room tempera-
ture. They were permeabilized with 0.1% Triton
 
 
 
X-100 in PBS and
blocked by 1% BSA in PBS. Stainings with Alexa-labeled phalloidin were
performed according to the manufacturer’s protocol (Molecular Probes
Inc.). The fixed cultures were finally covered with moviol.
 
Evaluation of Data
 
Analysis was done using an Axiophot (Zeiss) fluorescence microscope us-
ing a Sony CCD-camera together with the Analysis program (SIS). To
quantify outgrowth real-time pictures were taken and directly measured
on the screen. The average axon length of a culture was determined as the
distance from the explant to the region reached by at least 60% of the ax-
ons (longer and shorter neurites were not considered) (see Fig. 3 A).
Growth cone morphology was analyzed by measuring two diameters of a
growth cone using a 100
 
3
 
 objective (see Fig. 3 B). The d1 parameter rep-
resents the length of the growth cone in 
 
m
 
m, measured from the growth
cone-axon neck to the border of the leading lamellae, and the d2 parame-
ter represents its width, characterized mainly by the extension of its lamel-
lipodia.
 
 
 
The data were analyzed by regression analysis, ANOVA, and Stu-
dent’s 
 
t
 
 test using the EXCEL 98 program (Microsoft) and StatView 4.5
(Abacus Concepts Inc.).
 
Results
 
The CRYP
 
a
 
 Ligand Is Expressed in the Retinal
Basal Membrane
 
Immunostaining with CRYP
 
a
 
-specific antibodies strongly
labels retinal axons inside the retina, optic nerve, and tract,
and in the optic tectum of the chick embryo (Stoker et al.,
1995b; Ledig et al., 1999). CRYP
 
a
 
 is already present at E4
on retinal axons and growth cones. Two isoforms of
CRYP
 
a
 
, CRYP
 
a
 
1 and 
 
a
 
2 (Fig. 1), were described, both
containing 3 Ig-like domains but differing in the number of
fibronectin type III-like domains (FNIII). 
 
a
 
1 has four and
 
a
 
2 has eight FNIII repeats, respectively (Stoker et al.,
1995b). Until E7, only CRYP
 
a
 
1 is expressed in retinal
ganglion cells, whereas CRYP
 
a
 
2 is coexpressed by E8
(Haj et al., 1999). We suggest, therefore, that for the early
stages of retinal optic fiber growth, CRYP
 
a
 
1 is the rele-
vant isoform. To examine the expression of potential
ligands of this PTP, the extracellular domain of the
CRYP
 
a
 
1 isoform was fused to the enzyme alkaline phos-
phatase (Fig. 1) and the fusion protein 
 
a
 
1-AP was used to
analyze the localization of the ligands in the developing
chick retinotectal system (Haj et al., 1999). Using 
 
a
 
1-AP
(see Fig. 4 A), a ligand was detected at E6 in the basal
membrane of the retina (see Fig. 4 B), the optic stalk and
the optic chiasm (Haj et al., 1999) and in many basal mem-
branes throughout the embryonic brain (Stoker, A.W., un-
published observations).
 
Blocking CRYP
 
a
 
-Ligand Interactions Reduces Retinal 
Axon Length
 
The expression of the putative ligand in the retinal basal
membrane prompted us to use this membrane as a growth
substrate for retinal axons and to analyze what role the in-
teraction of CRYP
 
a
 
 with its ligand has in retinal axon
growth. To this end, retinal basal membranes were iso-
Figure 1. Schematic diagram of receptor tyrosine phosphatase
CRYPa isoforms and the soluble alkaline phosphatase (AP) fu-
sion proteins used in this study.
Figure 2. The basal membrane assay. An E6 retina was first dis-
sected and flatmounted on a nitrocellulose membrane filter
(MF), and then put upside down onto a PLL-coated glass cover-
slip, weightened, and incubated for 10 min (A). After lifting the
filter up the basal membrane (BM) sticks to the surface of the
glass coverslip (B) (Scheme after Kroeger, 1989). 
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lated according to a published method (Halfter et al.,
1987) and retinal strips were explanted. Retinal axons
were grown on retinal basal membranes or on laminin
for 24 h either in the presence of polyclonal antibodies
directed against the two outermost Ig-like domains of
CRYP
 
a
 
 (IG2 antibody; Fig. 1), or in the presence of 
 
a
 
1-
AP, thereby disturbing ligand-receptor interactions. Im-
portantly, the IG2 antibody is known to block the binding
of 
 
a
 
1-AP to the basal membrane ligand (see Haj et al.,
1999) and therefore is predicted to block CRYP
 
a
 
 ligand
interactions in general. A fusion protein containing the 3 Ig
domains of CRYP
 
a
 
 (Fig. 1; Ig3-AP) was used as a nega-
tive control, as previous experiments suggested that this
protein does not to bind to the CRYP
 
a
 
 ligand (Haj et al.,
1999). To analyze the effect of disturbing the CRYP
 
a
 
-
ligand interaction, the average length of retinal axons leav-
ing the explant was measured from the edge of the explant
to the front of the majority of axons (Fig. 3 A).
The IG2 antibody and 
 
a
 
1-AP strongly reduced the
length of retinal axons, in a dose-dependent manner on
BM (Fig. 5, A and C). We obtained the same result in
preliminary studies with IG2 antibodies on the tectal
membrane stripe assay (Walter et al., 1987) with tectal
membrane preparations (Ledig, M.M., and B.K. Mueller,
unpublished data). Outgrowth of both nasal and temporal
axons was reduced, but there was no effect on the decision
behavior (data not shown). 125 pmol of IG2 reduced reti-
nal axon length by 63% on basal membrane and by 25%
on LN (Fig. 5, A and B). 26 pmol 
 
a
 
1-AP reduced retinal
axon length on BM by 
 
z
 
50% (Fig. 5 C). No comparable
effect was observed with Ig3-AP on BM
 
 
 
(data not shown)
or
 
 
 
with 
 
a
 
1-AP or Ig3-AP
 
 
 
when retinal axons were grown
on LN (Fig. 5 D). A slight dose-dependent effect, caused
by the alkaline phosphatase (AP), was observed on both
LN and retinal BM, but only when used at high levels
(compare Fig. 5, C and D, with controls in A and B). 125
pmol of NCAM antibody was used as a control for anti-
body binding and did not influence retinal axon length on
LN or BM (Figs. 5, E and F, respectively). Moreover,
there were also no obvious effects on fasciculation by IG2
or by the polyclonal control antibody NCAM (data not
shown).
A second antibody, directed against the 
 
b
 
1-integrin
chain (JG22), was used to compare the effect of CRYP
 
a
 
1
to one of the major receptors for ECM molecules. Using
this antibody significantly reduced retinal axon length in a
dose-dependent manner on both substrates. 125 pmol of
JG22 blocked retinal axon growth on LN almost com-
pletely (Fig. 5 F). On BM retinal axon length was reduced
by 71% (Fig. 5 E). This suggests the presence of different
outgrowth promoting activities in basal membranes, medi-
ating their effects by at least two different receptor sys-
tems, the integrins, and the RPTP CRYP
 
a
 
.
 
Blocking CRYP
 
a
 
 Ligand Interactions Alters Retinal 
Growth Cone Morphology
 
The d1 and d2 parameters were used to measure growth
cone extensions (Fig. 3 B). Retinal axons growing on the
retinal basal membrane or on laminin exhibit a morphol-
ogy with few filopodia but elaborate lamellipodia (Fig. 6
A). In the presence of increasing amounts of IG2 or 
 
a
 
1-
AP, lamellipodia are gradually retracted and the number
of long filopodia is increased (Fig. 6, B–D and F–H). This
striking transition from a lamellipodial to a filopodial
growth cone morphology was most evident after adding
125 pmol IG2 or 26 pmol of 
 
a
 
1-AP (Fig. 6, D and H) (Ta-
ble I). Significantly, this was only observed on retinal BM
(Figs. 6, A–H, and 9 A) but not on LN (Figs. 6, I–P, and 9
B). The transition in growth cone morphology was re-
flected in a 
 
.
 
40% reduction of the growth cone width (d2)
without any significant change of its length (d1) (Fig. 9, A
and B) (Table I). Neither control antibody anti-NCAM
(125 pmol) nor AP (30 pmol) influenced retinal growth
cone morphology on either substrate (Figs. 6, E and M, 8,
D and E, and 9, C and D). A similar change in growth
cone morphology was observed after adding 62.5 or 125
pmol of the 
 
b
 
1 integrin antibody JG22 (Figs. 8, J and M,
and 9 C). In contrast to inhibition of the CRYP
 
a
 
 ligand in-
teraction, the morphological change seen with JG22 was
not restricted to growth cones on BM but was also found
Figure 3. Criteria for data analysis. A shows a control culture on
BM after a 24-h incubation time. We defined the average axon
outgrowth as the distance between the explant and the growth
front covered by at least 60% of the axons. B demonstrates how
growth cone data were measured. A growth cone grown on LN
was characterized by its two diameters d1 and d2. The arrow indi-
cates lamellipodia and the arrowhead filopodia of the growth
cone. Bars: (A) 0.1 mm; (B) 0.01 mm. 
Ledig et al. 
 
CRYP
 
a
 
 Promotes Retinal Axon Outgrowth
 
379
 
for growth cones growing on LN (Figs. 8, K and N, and 9
D; Table I).
Therefore, blocking the interaction of the RPTP CRYP
 
a
 
with its ligand from either the receptor or the ligand side,
not only reduced retinal axon length but induced a signifi-
cant shift in the morphology of retinal growth cones to a
more filopodial appearance. This suggests that CRYP
 
a
 
 ac-
tion influences the maintenance of lamellipodia when
growth cones are migrating on the intact retinal BM sub-
strate.
 
The CRYP
 
a
 
 Ligand Is Found on Glial Endfeet
 
The retinal basal membrane contains the endfeet of the
Mueller glia cells. These endfeet are visible under micro-
scopic bright field illumination and are stained by Alexa-
phalloidin (Fig. 6). Using such a staining procedure, end-
feet appear as dot like structures with a diameter of z2 mm
and with a ring-like F-actin organization. Incubating the
a1-AP protein on E7 basal membranes resulted in staining
of only these glial endfeet (Fig. 4 D). This suggests that the
putative ligand for CRYPa1 is located on the glial endfeet.
We tested this possibility by removing the endfeet from
the retinal BM. Removal of the endfeet was performed by
washing the retinal basal membrane with 2% Triton X-100
in PBS according to a published protocol (Halfter et al.,
1987) and resulted in a completely transparent basal mem-
brane (BM-Ef). In accordance with our hypothesis, there
was no detectable staining of BM-Ef using the a1-AP pro-
tein (Fig. 4 E).
Figure 4. A shows the a1-AP
fusion protein in cos7 cell su-
pernatant, immunodetected
with IG2 sera. a1-AP consists
of the extracellular domain of
CRYPa, which has a molecu-
lar weight of z90 kD to-
gether with the alkaline phos-
phatase of 65 kD. B and C
show binding of the a1-AP
fusion protein to a section of
the E6 retina, visualized with
AP staining. C is the cor-
responding phase contrast
view. Arrows indicate stain-
ing in the BM of the retina.
The arrowheads indicate the
pigment epithelium. D shows
binding of the a1-AP fusion
protein to a BM from a E7
retina, visualized with AP
staining. The stained dots
represent glial endfeet. There
is no binding of a1-AP to an
E7 detergent-washed end-
feet-free BM detectable as
can be seen in E. Abbrevia-
tions: BM, basal membrane;
Ret, retinal cell layer; PE,
pigmented epithelium. Bars:
(B and C) 0.1 mm; (D and E)
0.01 mm.
Table I. Statistical Analysis of Growth Cone Morphology
Substrate 1 antibody n
Growth cone
diameter 6
SEM P
mm
BM Control d1 60 12.86 6 2.59 vs. BM-Ef, ,0.0001
d2 60 11.24 6 2.08 vs. BM-Ef, ,0.0001
BM 20 mg NCAM d1 40 12.22 6 1.63 NS
d2 40 10.98 6 1.49 NS
BM 20 mg IG2 d1 40 11.74 6 1.36 NS
d2 40 5.14 6 1.36 ,0.0001
BM 20 mg b-integrin d1 40 7.07 6 4.93 ,0.0001
d2 40 3.75 6 2.85 ,0.0001
LN Control d1 40 15.22 6 2.23 vs. BM, 0.0014
d2 40 13.23 6 2.54 vs. BM, 0.0016
LN 20  mg NCAM d1 40 13.99 6 2.22 NS
d2 40 14.96 6 1.95 NS
LN 20 mg IG2 d1 40 12.95 6 2.83 0.0059
d2 40 12.96 6 3.31 NS
LN 20 mg b-integrin d1 40 Not detectable
d2 40 Not detectable
BM-Ef Control d1 40 17.44 6 1.96 vs. LN, 0.0002
d2 40 16.41 6 2.88 vs. LN, ,0.0001
BM-Ef 20 mg NCAM d1 40 17.61 6 2.94 NS
d2 40 16.26 6 2.26 NS
BM-Ef 20 mg IG2 d1 40 15.32 6 2.39 0.0163
d2 40 15.35 6 2.08 NS
BM-Ef 20 mg b-integrin d1 40 5.40 6 5.96 ,0.0001
d2 40 2.59 6 2.84 ,0.0001
n, Number of measured growth cones (10 growth cones from 4/6 independent experi-
ments were analyzed); P, values from single-factor ANOVA analyzing the influence
of IG2 on the same substrate and the influence of the different substrates themselves,
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Washing away the endfeet demonstrated the enormous
outgrowth-promoting potential of the ECM. Whereas the
average axon length in controls was almost the same on
LN and BM, removal of the endfeet caused an increase in
the average axon length of .40% (Fig. 7 and Table II).
However, growth on BM-Ef was much less susceptible to
inhibition with IG2. IG2 inhibited axon growth on com-
plete BM by 63%, but inhibition of growth on BM-Ef was
slight and similar to that seen on LN (25–30%; Fig. 7). As
an additional control for specificity of inhibition by IG2
antibodies, we tested matrigel, an acellular basement
membrane preparation from EHS sarcoma cells that lacks
detectable CRYPa ligand (McKinnell, I., and A. Stoker,
unpublished work). This was considered appropriate be-
Figure 5. Quantification of
the effect of IG2 and a1-AP
on neurite outgrowth on LN
and BM. E6 retinal explants
were cultured on either LN or
BM with the amounts of anti-
body indicated below the bars.
IG2 and a1-AP reduced the
average length of axon out-
growth on BM in a dose-depen-
dent fashion (A and C). IG2
also showed a significant ef-
fect on LN (B). No effect was
observed for a1-AP on LN
(D). To address the possibility
of an effect induced by anti-
body cross-linking we used
anti-NCAM as a control. No
effect of 20 mg anti-NCAM
was observed on either LN or
BM (E and F). Anti-b-inte-
grin JG22 was used as a com-
parison for IG2. On BM neu-
rite outgrowth was affected in
a dose-dependent manner by
JG22 (E) while on LN out-
growth was almost com-
pletely blocked by an amount
of 20 mg antibody (F). One
datapoint represents a mea-
surement of one retinal strip
from an independent experi-
ment performed with at least
one retinal strip. Double as-
terisks indicate P , 0.0001.Ledig et al. CRYPa Promotes Retinal Axon Outgrowth 381
cause most brain BMs at stage E6 are ligand-positive, and
other BMs are very difficult to isolate. Axon growth on
matrigel was as prolific as on BM-Ef, and was completely
unaffected by IG2 (Fig 7). Finally, anti N-CAM antibody
had no influence on retinal axon growth on any substrate
(Fig. 7 and Table II). These results suggest that the ligand
of the PTP CRYPa is located predominantly on retinal
glial endfeet structures.
On intact BMs, the anti-b1-integrin antibody (JG22) re-
duced outgrowth by z70%, suggesting that, in addition to
CRYP-a interactions, ECM/integrin interactions are im-
portant regulators of axon growth on this tissue. As ex-
pected, inhibition of axon growth by JG22 was even
greater when BM-Ef was tested, and outgrowth on LN was
completely blocked. In contrast, axon growth on matrigel
was inhibited only 48% by JG22. This result suggests that
matrigel contains growth-promoting substances in addi-
tion to the well-characterized ECM components that are
completely susceptible to inhibition by integrin antibodies
(Tomaselli et al., 1986). PLL/N-cadherin mediated out-
growth was not affected by either IG2 or JG22 (Fig. 7 and
Table II).
Comparison of the morphology of retinal growth cones
on the three different substrates (LN, BM, and BM-Ef) re-
vealed that growth cones on LN (Figs. 8 B and 9 D) and
BM-Ef (Figs. 8 C and 9 E) are more elaborate, possessing
larger d1 and d2 parameters, than growth cones on BM
(Figs. 8 A and 9 C). Blocking the interaction of the RPTP
CRYPa with its ligand-affected growth cone morphology
on BM (Figs. 8 G and 9 C) but not on BM-Ef (Figs. 8 I and
9 E), LN (Figs. 8 H and 9 D), or matrigel (data not shown).
Growth cone morphology on BM-Ef was affected by JG22
Figure 6. The morphology of
the growth cone is affected
by treatment with IG2 anti-
body or a1-AP fusion protein
in a substrate-dependent
manner. Effects on morphol-
ogy were seen on BM (B–D
and F–H), but not on LN
(J–L and N–P). On BM
growth cone lamellipodia
were retracted in a dose-
dependent manner when
adding either IG2 (A–D) or
a1-AP (E–H). Arrows indi-
cate glial endfeet structures.
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in the same way as on LN (compare Fig. 8, L and O with K
and N). For statistical data see Table I.
Discussion
In recent years, evidence has accumulated that RPTPs
play important roles in axon growth and guidance (re-
viewed in Chien, 1996; Desai et al., 1997a; Gershon et al.,
1998; Wills et al., 1999b). Nearly all of this evidence comes
from studies in invertebrates, especially from Drosophila
and leech. Far less is known about the role of RPTPs in
the nervous system of vertebrates. Here we present data
from in vitro experiments in which we examined the role
of the RPTP CRYPa in the growth of retinal axons to-
wards the optic fissure.
Previous experiments have shown that CRYPa is ex-
pressed at very early stages on retinal axons and growth
cones (Stoker et al., 1995a; Ledig et al., 1999). The finding
that a currently unknown ligand is present on basal mem-
branes of the eye, optic nerve, optic tract, and tectum,
pointed to an important role of this receptor and its ligand
in intraretinal axon growth and during growth of retinal
axons towards their target, the tectum opticum (Haj et al.,
1999). Blocking the CRYPa-ligand interaction from both
the receptor (IG2 antibodies) and the ligand side (a1-AP)
induced dramatic changes in growth cone morphology and
retinal axon length on the in vivo-like BM substrate. No
effects on growth cone morphology and only weak effects
on outgrowth were observed on a laminin substratum, on
the physiological ECM substratum matrigel and on deter-
gent-washed, endfeet-free basal membranes. We also ob-
served no changes in outgrowth or growth cone morphol-
ogy when we used Ig3-AP, a truncated form of CRYPa
with no ligand binding capacity (Ledig, M., unpublished
work; Haj et al., 1999). Taken together with the a1-
AP staining pattern on BM we suggest that the elusive
CRYPa ligand is found predominantly on the surface of
endfeet of Müller glia cells. The ligand itself exerts growth
promoting and growth cone lamellipodia-stimulating ac-
tivities.
Figure 7. Quantification of the influence of the growth substrate.
Removal of the glial endfeet from BM resulted in strong increase
in average axon length. The effect of IG2 is strongest on BM,
nearly equal on BM and LN. Both effects are statistically signifi-
cant (P , 0.0001). There was almost no effect of IG2 on matrigel
and on N-cadherin. In the presence of glial endfeet JG22 exhibits
weaker effects on axon outgrowth than on matrigel, BM-Ef, or
LN. Anti-NCAM had no effect on any substrates. Double aster-
isks indicate P , 0.0001. See Table II for data.
Table II. Statistical Analysis of the Average Axon Length
Substrate 1 antibody n
Average axon
length 6 SEM
P
P1 P2
mm
BM Control 19 642.0 6 83.4 — vs. LN, NS
BM 20 mg NCAM 6 634.0 6 93.7 NS vs. LN, NS
BM 20 mg IG2 16 232.4 6 27.3 ,0.0001 vs. LN, ,0.0001
BM 20 mg b-integrin 9 184.2 6 57.0 ,0.0001 vs. LN, 0.0001
LN Control 14 635.5 6 85.5 — vs. BM-Ef, ,0.0001
LN 20 mg NCAM 8 698.2 6 76.1 NS vs. BM-Ef, NS
LN 20 mg IG2 9 442.8 6 53.1 ,0.0001 vs. BM-Ef, ,0.0001
LN 20 mg b-integrin 5 20.4 6 25.8 ,0.0001 vs. BM-Ef, 0.0004
BM-Ef Control 8 1073.6 6 209.3 — vs. BM, ,0.0001
BM-Ef 20 mg NCAM 8 1014.8 6 119.4 NS vs. BM, ,0.0001
BM-Ef 20 mg IG2 13 796.6 6 94.3 0.0015 vs. BM, ,0.0001
BM-Ef 20 mg b-integrin 6 220.6 6 69.7 ,0.0001 vs. BM, NS
MG Control 9 970.4 6 173.3 — vs. BM-Ef, NS
MG 20 mg NCAM 3 883.8 6 65.7 NS vs. BM-Ef, NS
MG 20 mg IG2 11 909.8 6 109.7 NS vs. BM-Ef, 0.014
MG 20 mg b-integrin 7 470.5 6 74.4 ,0.0001 vs. BM-Ef, 0.001
NC/PLL Control 9 281.5 6 35.9 — —
NC/PLL 20 mg NCAM 3 256.8 6 30.9 NS —
NC/PLL 20 mg IG2 6 252.7 6 41.3 NS —
NC/PLL 20 mg b-integrin 3 213.4 6 5.8 0.0014 —
n, Number of independent experiments with at least two retinal strips; P1, values from single-factor ANOVA (ANOVA was used because most of the data show a normal distribu-
tion) analyzing the influence of different antibodies on the same substrate, 99% confidence interval; P2, values from single-factor ANOVA analyzing the influence of the growth
substrate when treated with the same antibody, 99% confidence interval (the substrate that was used for the comparison is indicated); NS indicates no significance (statistical val-
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We have demonstrated that the glial endfeet of the reti-
nal BM contain a balance of positive and negative cues.
For example, removal of the glial endfeet leads to an enor-
mous increase in axon outgrowth on BMs, whereas only
on intact BMs do antibodies to CRYPa and the CRYPa1-
AP fusion protein induce dramatic reductions in out-
growth. Previous data have demonstrated that the net out-
come of these factors is indeed permissive for retinal axon
growth (Stier and Schlosshauer, 1999). In the presence of
these endfeet, the disturbance of CRYPa-ligand interac-
tions causes a strong decrease of axon outgrowth. This
suggests that during normal, intraretinal axon outgrowth,
the growth-facilitating or -promoting role of CRYPa is in
constant balance with negative influences on the growth
cone. Therefore, this work places the RPTPs in a critical
position in the regulation of intra-growth cone phosphoty-
rosine levels and maintenance of axon outgrowth (Cum-
mings, 1999).
Glial endfeet are present on retinal basal membranes
(Bauch et al., 1998), but their molecular components are
not completely characterized. The laminin/nidogen com-
plex is present in the BM (Cohen et al., 1987). It was re-
cently shown that this complex binds in vitro to the fifth fi-
bronectin type III domain of the long isoform of LAR
Figure 8. Comparison of the
effect of IG2 on different
growth substrates and to the
change in growth cone mor-
phology induced by blocking
the integrin receptor. Anti-
NCAM was used as poly-
clonal control antibody (D–
F). After removal of glial
endfeet IG2 no longer has an
effect on growth cone mor-
phology (compare A–C with
G–I), meaning that the ligand
must be located on the glial
endfeet. Axon growth is
largely mediated via the inte-
grin receptor. Laminin, one
of the integrin ligands is lo-
cated in the ECM. Therefore,
blockage of the integrin re-
ceptor  b-subunit results in an
effect on all substrates (J–O)
that is dose-dependent (com-
pare J–L with M–O). Inter-
estingly growth cones are less
affected in the presence of
glial endfeet (J and M). Bar,
0.02 mm.The Journal of Cell Biology, Volume 147, 1999 384
(O’Grady et al., 1998), an RPTP structurally related to
CRYPa2. However, this isoform of LAR is not expressed
in the nervous system. We would not expect a similar in-
teraction of CRYPa1 with laminin, as in vitro binding
assays failed to detect an interaction of CRYPa1 or
CRYPa2 with laminin 1 or 2 (Haj et al., 1999; McKinnell,
I.W., and A.W. Stoker, unpublished work). In the same in
vitro assays, matrigel did not bind to CRYPa. Recent
work also suggests that CRYPa does not interact ho-
mophilically (Haj et al., 1999). These data underline
our idea that the CRYPa ligand is a currently unknown
transmembrane, membrane-anchored, or membrane-asso-
Figure 9. Quantification of
growth cone morphology on
different substrates. On BM
both IG2 and a1-AP affect
growth cone morphology. D2
is significantly reduced in
a dose-dependent manner
while d1 is not affected at all
(A). There was no effect on
LN (B). Comparing the influ-
ence of both antibody and
growth substrates it is re-
markable that growth cones
on LN and BM-Ef are larger
in their overall size compared
with ones grown on BM (C–
E). Moreover, treatment with
IG2 only had a significant ef-
fect on d2 of growth cones
grown on BM (C), but not on
LN (D) and BM-Ef (E).
When using 125 pmol JG22
there were not any growth
cones detectable on LN (D).
Growth cone morphology
was less, but still heavily af-
fected on BM-Ef (E) and BM
(C) (** indicate statistical sig-
nificance P , 0.0001). See
Table I for data.Ledig et al. CRYPa Promotes Retinal Axon Outgrowth 385
ciated molecule at the surface of the endfeet of Mueller
glia cells (Fig. 10).
On BM-Ef, neurite growth signals are mainly integrated
via  b1 integrin receptors (Sakaguchi and Radke, 1996).
Blocking the b1-subunits of the integrin receptors results
in an enormous reduction of outgrowth. Due to the diffi-
culties in isolating a native, ligand-negative basal mem-
brane, we chose matrigel as a physiological control sub-
strate that lacks detectable a1-AP binding activity. The
results obtained on matrigel are largely the same than on
BM-Ef, except that outgrowth on matrigel is less affected
by blocking the integrin receptor. This suggests, unsurpris-
ingly, that matrigel matrix contains additional growth-pro-
moting components aside from laminin and the putative
CRYPa ligand.
Blocking the interaction of CRYPa with its ligand as
well as the integrin receptor resulted in a dose-dependent
loss of growth cone lamellipodia and in a transition to-
wards a more filopodial morphology. Although this could
relate to the reduced growth rate in both treatments, this
does not imply that a filopodial morphology is always dis-
advantageous for growth cone migration (e.g., Bovolenta
and Mason, 1987). The data also indicate that both inte-
grins and CRYPa can both influence lamellipodial dynam-
ics, either independently or synergistically. What could be
the link between CRYPa and lamellipodia?
Well-known molecular regulators of lamellipodia and
filopodia in fibroblasts are the small GTP-binding proteins
of the Rho family, Rac and Cdc42, respectively (Nobes
and Hall, 1995, 1999; Hall 1998). Available evidence sug-
gests that they exert similar functions in neuronal growth
cones (reviewed in Mueller, 1999). Control of the growth
cone actin cytoskeleton by RPTPs could be achieved by
interacting adapter proteins, like Trio. Trio binds to the in-
tracellular domain of the CRYPa family member, LAR,
and has two guanine exchange factor domains specific for
Rac and Rho (Debant et al., 1996; Bellanger et al., 1998).
Furthermore, the Caenorhabditis elegans Trio homologue,
UNC-73, was shown to be required for axon growth and
guidance (Steven at al., 1998). The phenotypic similarities
of null mutants for DLAR and the Drosophila Rac suggest
their interaction in guidance of intersegmental nerve b
(Kaufmann et al., 1998). Further evidence for an impor-
tant function of RPTPs in controlling the actin cytoskele-
ton comes from two recent papers showing that profilin is
regulated by DLAR involving the cytoplasmic tyrosine ki-
nase abl and its substrate enabled (Wills et al., 1999a,b).
Trio could also provide a connection between DLAR and
profilin via Rho and phosphatidylinositol 4-phosphate
5-kinase (Chong et al., 1994).
From our data that blocking of CRYPa-ligand interac-
tions on BM leads to changes in the actin cytoskeleton and
to lamellipodia formation, it seems most likely that the
CRYPa downstream signaling pathway also involves Rac.
This may be related to a similar process as shown for inte-
grins (Keely et al., 1997; Clark et al., 1998; Kuhn et al.,
1998) (Fig. 10). There is likely to be considerable cross-
talk between RPTPs and other extracellular receptors.
This is especially important for recognition of multiligand
complexes consisting of cell adhesion molecules and other
growth cone guidance activities (Holland et al., 1998). The
downstream signaling pathways of both CRYPa and inte-
grin receptors seem to converge as well. There are several
examples for an interplay of RPTPs and integrins (Shenoi
et al., 1999; Su et al., 1999), and it is quite likely that the
same is true for CRYPa. The LAR-interacting protein
(LIP) localizes type II RPTPs to focal adhesions (Serra-
Pages et al., 1995, 1998; Pulido et al., 1995), and, therefore,
brings them into the close neighborhood of integrins. An
interplay between RPTPs and integrin could then happen
on the level of the small GTPases and Src-family of cyto-
plasmic kinases (Schlaepfer and Hunter, 1998), both of
which are shared in downstream pathways. This could re-
sult in the joint control of adhesive and deadhesive prop-
erties of cells or growth cones (Helmke et al., 1998). Such
a relationship has been shown, for example, with the T and
B cell RPTP CD45 and integrins (Roach et al., 1997;
Shenoi et al., 1999).
Figure 10. Our data indicate that there is a yet unknown ligand
located on or associated with glial endfeet of retinal Müller glia
cells. Signaling into the growth cone is mediated via the CRYPa1
receptor. These signals are important for outgrowth and the actin
cytoskeleton. According to the work from other groups, it is
likely that downstream signaling is mediated via the Trio protein,
which is capable of activating rac and rho. The integrin receptor
mediates the laminin signal from the ECM into the growth cone.
It has been previously shown that integrin downstream activates
Rac and Cdc42. So both receptors mediate signals, that are im-
portant for axon outgrowth and growth cone morphology. The
CRYPa1-ligand interaction is growth-promoting and could bal-
ance a negative interaction between the growth cone and Müller
glia cells. The glial endfeet, therefore, appear to have a strict
growth controlling function containing a balance of growth pro-
moting and inhibiting factors on their surfaces.The Journal of Cell Biology, Volume 147, 1999 386
Based on the data we have presented, we can formulate
a basic model for some of the signaling processes down-
stream of CRYPa and integrins in retinal growth cones
(Fig. 10). It is clear that laminin-integrin interactions alone
can stimulate growth cone migration and lamellipodia for-
mation in the absence of other incoming signals (Toma-
selli et al., 1986). On a complete BM, however, we suggest
there is a positive, CRYPa-dependent signal and a balanc-
ing negative signal(s) coming from an independent ligand-
receptor complex. The latter signal could partly suppress
integrin-promoted outgrowth and lamellipodia formation,
by downregulating, directly or indirectly, the Rac pathway.
This is counteracted by the positive CRYPa signal. Thus,
loss of CRYPa signal in our experiments induces a signifi-
cant block in neurite outgrowth. The modest influence of
the IG2 antibody on a pure laminin substrate could be
partly explained by a low level of activity in both the
CRYPa and negative signals, in the absence of their cog-
nate ligands. CRYPa antibodies would then cause a only
slight suppression of integrin-mediated outgrowth, with-
out grossly altering lamellipodia. This model needs to be
tested further, but possible candidates for the negative sig-
nals would include nongraded Eph receptors, and their
ephrin ligand, which are known to be present on glial end-
feet (Braisted et al., 1997). Another interesting possibility
could be that there are some cis-interactions between inte-
grins and CRYPa on the growth cone.
PTPm, another membrane tyrosine phosphatase, was
recently shown to mediate homophilic trans-interactions
(Gebbink et al., 1995; Zondag et al., 1995), and to be in-
volved in retinal axon growth (Burden-Gulley and Brady-
Kalnay, 1999). PTPm interacts with three different, cal-
cium-dependent cell adhesion molecules, N-, R-, and
E-cadherin (Brady-Kalnay et al., 1998; Burden-Gulley
and Brady-Kalnay, 1999). It was shown that N- and
R-cadherin promote outgrowth of neurites (e.g., Bixby
and Zhang, 1990; Redies and Takeichi, 1993). Used as a
substrate, PTPm stimulated neurite outgrowth of E8 chick
RGC neurites and on an N-cadherin substrate; downregu-
lation of this phosphatase resulted in a significant de-
crease of the retinal neurite length, suggesting that the
phosphatase activity of PTPm is important for growth of
RGC neurites on N-cadherin (Burden-Gulley and Brady-
Kalnay, 1999).
RPTPb/PTPz is another outgrowth-inducing RPTP (Peles
et al., 1995; Sakurai et al., 1997). It binds to other mem-
bers of cell surface recognition complexes, among them
contactin/F11 (Brümmendorf et al., 1998) and Nr-CAM,
enabling signal transduction into the growth cone (Peles
et al., 1998). But the relevance of this RPTP for the devel-
opment of the retinotectal system remains to be eluci-
dated.
During formation of the retinotectal map, there now ap-
pear to be, besides the integrins and N-cadherin, at least
two different RPTPs involved in outgrowth of retinal gan-
glion cell axons: CRYPa and its yet undefined ligand,
and PTPm. Our results suggest that besides the RTKs
(Drescher et al., 1997; Mueller et al., 1996), RPTPs such as
CRYPa play an extremely important, complementary role
in promoting formation of the visual system. It remains to
be seen if gene deletion of RPTPs such as the mammalian
orthologue of CRYPa, RPTPs (Elchebly et al., 1999; Wal-
lace et al., 1999), results in disturbance of the retinotectal
projection.
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